BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, Fusté LC, Heinz-Peer G, Judmaier W, Laniado M. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2008;18:457-467. [PMID: 18058107 DOI: 10.1007/s00330-007-0716-9] [Cited by in Crossref: 301] [Cited by in F6Publishing: 271] [Article Influence: 20.1] [Reference Citation Analysis]
Number Citing Articles
1 Tanimoto A, Min Lee J, Murakami T, Huppertz A, Kudo M, Grazioli L. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009;19:975-89. [DOI: 10.1007/s00330-009-1624-y] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 6.5] [Reference Citation Analysis]
2 Zech CJ, Vos B, Nordell A, Urich M, Blomqvist L, Breuer J, Reiser MF, Weinmann H. Vascular Enhancement in Early Dynamic Liver MR Imaging in an Animal Model: Comparison of Two Injection Regimen and Two Different Doses Gd-EOB-DTPA (Gadoxetic Acid) With Standard Gd-DTPA: . Investigative Radiology 2009;44:305-10. [DOI: 10.1097/rli.0b013e3181a24512] [Cited by in Crossref: 98] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
3 Chan VO, Das JP, Gerstenmaier JF, Geoghegan J, Gibney RG, Collins CD, Skehan SJ, Malone DE. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Ir J Med Sci 2012;181:499-509. [DOI: 10.1007/s11845-012-0805-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tong HF, Liang HB, Mo ZK, Guan TP, Yang J, Fang CH. Quantitative analysis of gadoxetic acid-enhanced magnetic resonance imaging predicts histological grade of hepatocellular carcinoma. Clin Imaging 2017;43:9-14. [PMID: 28153667 DOI: 10.1016/j.clinimag.2016.12.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol. 2012;85:980-989. [PMID: 22167501 DOI: 10.1259/bjr/91771639] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
6 Baird AJ, Amos GJ, Saad NF, Benson MD. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation. J Med Imaging Radiat Oncol 2013;57:314-20. [PMID: 23721140 DOI: 10.1111/1754-9485.12038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
7 Fowler KJ, Linehan DC, Menias CO. Colorectal liver metastases: state of the art imaging. Ann Surg Oncol. 2013;20:1185-1193. [PMID: 23115006 DOI: 10.1245/s10434-012-2730-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
8 Shin H, Jung YW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim YY, Choi JY, Kim SU. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B. Clin Mol Hepatol 2019;25:390-9. [PMID: 31146508 DOI: 10.3350/cmh.2018.0103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
9 Liu PS, Hussain HK. Contemporary and Emerging Technologies in Abdominal Magnetic Resonance Imaging. Seminars in Roentgenology 2013;48:203-13. [DOI: 10.1053/j.ro.2013.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology 2011;54:2227-37. [PMID: 21932400 DOI: 10.1002/hep.24679] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 7.3] [Reference Citation Analysis]
11 Muenzel D, Lo GC, Yu HS, Parakh A, Patino M, Kambadakone A, Rummeny EJ, Sahani DV. Material density iodine images in dual-energy CT: Detection and characterization of hypervascular liver lesions compared to magnetic resonance imaging. Eur J Radiol 2017;95:300-6. [PMID: 28987684 DOI: 10.1016/j.ejrad.2017.08.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
12 Golfieri R, Renzulli M, Lucidi V, Corcioni B, Trevisani F, Bolondi L. Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis. Eur Radiol 2011;21:1233-42. [DOI: 10.1007/s00330-010-2030-1] [Cited by in Crossref: 138] [Cited by in F6Publishing: 128] [Article Influence: 12.5] [Reference Citation Analysis]
13 Lee S, Kim SH, Park CK, Kim Y, Lee WJ, Lim HK. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: Pathological correlation. J Magn Reson Imaging 2010;32:719-25. [DOI: 10.1002/jmri.22291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Acher AW, Abbott DE. Rethinking Resection and Transplant Candidacy for HCC: Should Tumor Biology Replace Size-Based Criteria? Ann Surg Oncol 2020;27:1309-11. [PMID: 31728794 DOI: 10.1245/s10434-019-08081-5] [Reference Citation Analysis]
15 Lee NK, Kim S, Lee JW, Lee SH, Kang DH, Kim GH, Seo HI. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics. 2009;29:1707-1724. [PMID: 19959517 DOI: 10.1148/rg.296095501] [Cited by in Crossref: 148] [Cited by in F6Publishing: 127] [Article Influence: 12.3] [Reference Citation Analysis]
16 Ohnishi H, Sakaguchi K, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Miyake Y, Shoji B, Iwadou S, Shiratori Y. Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma. Hepatol Int 2010;4:562-8. [PMID: 21063478 DOI: 10.1007/s12072-010-9190-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
17 Ogul H, Kantarci M, Pirimoglu B, Karaca L, Aydinli B, Okur A, Ozturk G, Kizrak Y. The efficiency of Gd-EOB-DTPA-enhanced magnetic resonance cholangiography in living donor liver transplantation: a preliminary study. Clin Transplant 2014;28:354-60. [PMID: 24506817 DOI: 10.1111/ctr.12320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ringe KI, Hinrichs J, Merkle EM, Weismüller TJ, Wacker F, Meyer BC. Gadoxetate disodium in patients with primary sclerosing cholangitis: an analysis of hepatobiliary contrast excretion. J Magn Reson Imaging 2014;40:106-12. [PMID: 24923477 DOI: 10.1002/jmri.24381] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
19 Kim HY, Choi JY, Park CH, Song MJ, Song DS, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE. Clinical factors predictive of insufficient liver enhancement on the hepatocyte-phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging in patients with liver cirrhosis. J Gastroenterol. 2013;48:1180-1187. [PMID: 23354621 DOI: 10.1007/s00535-012-0740-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
20 Shimofusa R, Ueda T, Kishimoto T, Nakajima M, Yoshikawa M, Kondo F, Ito H. Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. Journal of Hepato-Biliary-Pancreatic Sciences 2010;17:583-9. [DOI: 10.1007/s00534-009-0198-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
21 Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf K, Albrecht T. Qualitative and Quantitative Evaluation of Hepatocellular Carcinoma and Cirrhotic Liver Enhancement Using Gd-EOB-DTPA. American Journal of Roentgenology 2009;193:1053-60. [DOI: 10.2214/ajr.08.1946] [Cited by in Crossref: 120] [Cited by in F6Publishing: 42] [Article Influence: 9.2] [Reference Citation Analysis]
22 Budjan J, Riffel P, Ong MM, Schoenberg SO, Attenberger UI, Hausmann D. Rapid Cartesian versus radial acquisition: comparison of two sequences for hepatobiliary phase MRI at 3 tesla in patients with impaired breath-hold capabilities. BMC Med Imaging 2017;17:32. [PMID: 28486977 DOI: 10.1186/s12880-017-0203-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
23 Lee JM, Choi BI. Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging 2011;36:282-9. [DOI: 10.1007/s00261-011-9692-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
24 Asato N, Tsurusaki M, Sofue K, Hieda Y, Katsube T, Kitajima K, Murakami T. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases. Jpn J Radiol 2017;35:197-205. [DOI: 10.1007/s11604-017-0622-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
25 Jeong S. Surgical Management of Colorectal Cancer. J Korean Med Assoc 2010;53:569. [DOI: 10.5124/jkma.2010.53.7.569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
26 Boal Carvalho P, Pereira E. Imagiological Diagnosis of Gastrointestinal Diseases - Diagnostic Criteria of Hepatocellular Carcinoma. GE Port J Gastroenterol 2015;22:153-60. [PMID: 28868398 DOI: 10.1016/j.jpge.2015.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging. 2009;30:849-854. [PMID: 19787734 DOI: 10.1002/jmri.21913] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
28 Ren W, Sell NM, Ferrone CR, Tanabe KK, Lillemoe KD, Qadan M. Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in the Neoadjuvant Setting. J Surg Res 2021;259:253-60. [PMID: 33160635 DOI: 10.1016/j.jss.2020.09.039] [Reference Citation Analysis]
29 Choi JY, Kim MJ, Park YN, Lee JM, Yoo SK, Rha SY, Seok JY. Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics. AJR Am J Roentgenol. 2011;197:399-405. [PMID: 21785086 DOI: 10.2214/ajr.10.5439] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
30 Ikuta Y, Takamori H, Ikeda O, Tanaka H, Sakamoto Y, Hashimoto D, Ozaki N, Nakahara O, Furuhashi S, Abe S, Beppu T, Shimada S, Yamashita Y, Baba H. Detection of liver metastases secondary to pancreatic cancer: utility of combined helical computed tomography during arterial portography with biphasic computed tomography-assisted hepatic arteriography. J Gastroenterol 2010;45:1241-6. [DOI: 10.1007/s00535-010-0285-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
31 Yoo SH, Choi JY, Jang JW, Bae SH, Yoon SK, Kim DG, Yoo YK, Rha SE, Lee YJ, Jung ES. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Ann Surg Oncol. 2013;20:2893-2900. [PMID: 23649931 DOI: 10.1245/s10434-013-3001-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
32 Chandarana H, Feng L, Ream J, Wang A, Babb JS, Block KT, Sodickson DK, Otazo R. Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. Invest Radiol 2015;50:749-56. [PMID: 26146869 DOI: 10.1097/RLI.0000000000000179] [Cited by in Crossref: 68] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
33 Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging 2015;41:251-65. [PMID: 25104398 DOI: 10.1002/jmri.24712] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
34 Fujinaga Y, Kadoya M, Kozaka K, Shinmura R, Matsui O, Takayama T, Yamamoto M, Kokudo N, Kawasaki S, Arii S. Prediction of macroscopic findings of hepatocellular carcinoma on hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging: Correlation with pathology. Hepatol Res 2013;43:488-94. [PMID: 22978417 DOI: 10.1111/j.1872-034X.2012.01089.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 Alwalid O, Wang Y, Fan W, Han P. Value of gadoxetic acid-enhanced MR imaging and DWI in classification, characterization and confidence in diagnosis of solid focal liver lesions. Scand J Gastroenterol 2021;56:72-80. [PMID: 33232614 DOI: 10.1080/00365521.2020.1847314] [Reference Citation Analysis]
36 Cha DI, Lee MW, Kim YK, Kim SH, Park HJ, Rhim H, Lim HK. Assessing patients with hepatocellular carcinoma meeting the Milan criteria: Is liver 3 tesla MR with gadoxetic acid necessary in addition to liver CT? J Magn Reson Imaging 2014;39:842-52. [PMID: 24115384 DOI: 10.1002/jmri.24237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
37 Péporté AR, Sommer WH, Nikolaou K, Reiser MF, Zech CJ. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI. Eur J Radiol. 2013;82:e101-e106. [PMID: 23159401 DOI: 10.1016/j.ejrad.2012.10.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
38 Bormann RL, da Rocha EL, Kierzenbaum ML, Pedrassa BC, Torres LR, D'Ippolito G. The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review. Radiol Bras 2015;48:43-51. [PMID: 25798007 DOI: 10.1590/0100-3984.2013.1794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
39 Nagle SK, Busse RF, Brau AC, Brittain JH, Frydrychowicz A, Iwadate Y, Reeder SB. High resolution navigated three-dimensional T(1) -weighted hepatobiliary MRI using gadoxetic acid optimized for 1.5 tesla. J Magn Reson Imaging. 2012;36:890-899. [PMID: 22648633 DOI: 10.1002/jmri.23713] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
40 Jin YJ, Lee JW, Kwon OS, Jung YK, Kwon JH, Jang JW, Kim YS, Kim TH, Jeon YS. Clinical effect of add-on Primovist-enhanced magnetic resonance imaging on preoperative tumor staging in hepatocellular carcinoma patients. J Surg Oncol 2016;114:106-11. [PMID: 27332047 DOI: 10.1002/jso.24272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Benz MR, Vargas HA, Sala E. Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine. Magn Reson Imaging Clin N Am 2016;24:1-10. [PMID: 26613872 DOI: 10.1016/j.mric.2015.08.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
42 Ringe KI, Wacker F. Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography. Best Pract Res Clin Gastroenterol. 2015;29:253-265. [PMID: 25966426 DOI: 10.1016/j.bpg.2015.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
43 Kim YK, Kim CS, Han YM, Lee YH. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial? Clin Radiol. 2011;66:489-496. [PMID: 21367403 DOI: 10.1016/j.crad.2010.09.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
44 Filippone A, Blakeborough A, Breuer J, Grazioli L, Gschwend S, Hammerstingl R, Heinz-Peer G, Kittner T, Laghi A, Leen E. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging. 2010;31:356-364. [PMID: 20099349 DOI: 10.1002/jmri.22054] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
45 Frydrychowicz A, Nagle SK, D'Souza SL, Vigen KK, Reeder SB. Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid. J Magn Reson Imaging 2011;34:585-94. [PMID: 21751288 DOI: 10.1002/jmri.22713] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
46 Tamada T, Ito K, Yamamoto A, Sone T, Kanki A, Tanaka F, Higashi H. Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium. AJR Am J Roentgenol. 2011;196:824-830. [PMID: 21427331 DOI: 10.2214/ajr.10.5113] [Cited by in Crossref: 38] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
47 Channual S, Tan N, Siripongsakun S, Lassman C, Lu DS, Raman SS. Gadoxetate Disodium-Enhanced MRI to Differentiate Dysplastic Nodules and Grade of Hepatocellular Carcinoma: Correlation With Histopathology. AJR Am J Roentgenol. 2015;205:546-553. [PMID: 26295640 DOI: 10.2214/ajr.14.12716] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
48 Duncan JK, Ma N, Vreugdenburg TD, Cameron AL, Maddern G. Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis. J Magn Reson Imaging 2017;45:281-90. [PMID: 27299482 DOI: 10.1002/jmri.25345] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
49 Burke C, Alexander Grant L, Goh V, Griffin N. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging. Semin Ultrasound CT MR 2013;34:44-53. [PMID: 23395317 DOI: 10.1053/j.sult.2012.11.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
50 Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol. 2008;43:504-511. [PMID: 18580333 DOI: 10.1097/rli.0b013e3181705cd1] [Cited by in Crossref: 173] [Cited by in F6Publishing: 68] [Article Influence: 12.4] [Reference Citation Analysis]
51 Costa EA, Cunha GM, Smorodinsky E, Cruite I, Tang A, Marks RM, Clark L, Wolfson T, Gamst A, Sicklick JK, Hemming A, Peterson MR, Middleton MS, Sirlin CB. Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard. Radiology 2015;276:775-86. [PMID: 25875972 DOI: 10.1148/radiol.2015142069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
52 Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, Araki T. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 2009;30:1042-1046. [PMID: 19856436 DOI: 10.1002/jmri.21956] [Cited by in Crossref: 173] [Cited by in F6Publishing: 165] [Article Influence: 14.4] [Reference Citation Analysis]
53 Zech CJ, Bartolozzi C, Bioulac-sage P, Chow PK, Forner A, Grazioli L, Huppertz A, Laumonier H, Min Lee J, Murakami T, Ricke J, Sirlin CB. Consensus Report of the Fifth International Forum for Liver MRI. American Journal of Roentgenology 2013;201:97-107. [DOI: 10.2214/ajr.12.9491] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
54 Schreyer AG, Grenacher L, Wessling J, Juchems M, Bazan Serrano GF, Ringe KI, Dendl LM. [Incidental and "leave me alone" findings of abdominal organs-part 1 : Liver, gall ducts and pancreas]. Radiologe 2022;62:351-64. [PMID: 35352138 DOI: 10.1007/s00117-022-00987-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Wang Q, Shi G, Qi X, Fan X, Wang L. Quantitative analysis of the dual-energy CT virtual spectral curve for focal liver lesions characterization. Eur J Radiol 2014;83:1759-64. [PMID: 25088350 DOI: 10.1016/j.ejrad.2014.07.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
56 Gomi T, Nagamoto M, Hasegawa M, Tabata A, Iwasaki M, Ooka M, Murata N, Tsunoo M, Iizuka Y, Kohda E, Shiraga N. Radial MRI during free breathing in contrast-enhanced hepatobiliary phase imaging. Acta Radiol 2014;55:3-7. [PMID: 23873886 DOI: 10.1177/0284185113492720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
57 Akai H, Kiryu S, Matsuda I, Satou J, Takao H, Tajima T, Watanabe Y, Imamura H, Kokudo N, Akahane M. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol. 2011;80:310-315. [PMID: 20732773 DOI: 10.1016/j.ejrad.2010.07.026] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
58 Agrawal MD, Agarwal S, Fuentes-oreego JM, Hayano K, Sahani DV. New Liver Imaging Techniques. Curr Radiol Rep 2013;1:294-306. [DOI: 10.1007/s40134-013-0028-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Benndorf M, Schelhorn J, Dietzel M, Kaiser WA, Baltzer PA. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. European Journal of Radiology 2012;81:e849-53. [DOI: 10.1016/j.ejrad.2012.03.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
60 Iwata H, Shibamoto Y, Hashizume C, Mori Y, Kobayashi T, Hayashi N, Kosaki K, Ishikawa T, Kuzuya T, Utsunomiya S. Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity. Technol Cancer Res Treat 2010;9:619-27. [PMID: 21070084 DOI: 10.1177/153303461000900610] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
61 Kawamura Y, Saitoh S, Arase Y, Ikeda K, Fukushima T, Hara T, Seko Y, Hosaka T, Kobayashi M, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Fukuzawa K, Hamada Y, Takahashi J, Kobayashi M, Kumada H. Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis. Hepatol Int 2013;7:850-8. [DOI: 10.1007/s12072-012-9419-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
62 Yeung JM, Ferris NJ, Lynch AC, Heriot AG. Preoperative staging of rectal cancer. Future Oncology 2009;5:1295-306. [DOI: 10.2217/fon.09.100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
63 Jang HY, Choi JI, Lee YJ, Park MY, Yeo DM, Rha SE, Jung ES, You YK, Kim DG, Byun JY. Performance of Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging for Predicting Patient Eligibility for Liver Transplantation Based on the Milan Criteria. J Comput Assist Tomogr 2017;41:25-31. [PMID: 27768617 DOI: 10.1097/RCT.0000000000000476] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
64 Chandarana H, Taouli B. Diffusion-weighted MRI and liver metastases. Magn Reson Imaging Clin N Am. 2010;18:451-464, x. [PMID: 21094449 DOI: 10.1016/j.mric.2010.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
65 Coimbra FJ, Ribeiro HS, Marques MC, Herman P, Chojniak R, Kalil AN, Wiermann EG, Cavallero SR, Coelho FF, Fernandes PH, Silvestrini AA, Almeida MF, de Araújo AL, Pitombo M, Teixeira HM, Waechter FL, Ferreira FG, Diniz AL, D'Ippolito G, D'Ippolito G, Begnami MD, Prolla G, Balzan SM, de Oliveira TB, Szultan LA, Lendoire J, Torres OJ. FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION. Arq Bras Cir Dig 2015;28:222-30. [PMID: 26734788 DOI: 10.1590/S0102-6720201500040002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
66 Shiozawa K, Watanabe M, Ikehara T, Matsukiyo Y, Kogame M, Kikuchi Y, Otsuka Y, Kaneko H, Igarashi Y, Sumino Y. Comparison of contrast-enhanced ultrasonograpy with Gd-EOB-DTPA-enhanced MRI in the diagnosis of liver metastasis from colorectal cancer. J Clin Ultrasound 2017;45:138-44. [PMID: 27861987 DOI: 10.1002/jcu.22421] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
67 Fujinaga Y, Ohya A, Matsushita T, Kurozumi M, Ueda K, Kitou Y, Ueda H, Kadoya M. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA. Jpn J Radiol 2011;29:695-700. [DOI: 10.1007/s11604-011-0615-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Fonseca GM, Herman P, Faraj SF, Kruger JAP, Coelho FF, Jeismann VB, Cecconello I, Alves VAF, Pawlik TM, de Mello ES. Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol. Histopathology. 2018;72:377-390. [PMID: 28858385 DOI: 10.1111/his.13378] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
69 Bieze M, van den Esschert JW, Nio CY, Verheij J, Reitsma JB, Terpstra V, van Gulik TM, Phoa SS. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol. 2012;199:26-34. [PMID: 22733890 DOI: 10.2214/ajr.11.7750] [Cited by in Crossref: 78] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
70 Motosugi U, Ichikawa T, Oguri M, Sano K, Sou H, Muhi A, Matsuda M, Fujii H, Enomoto N, Araki T. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index. Magn Reson Imaging. 2011;29:1047-1052. [PMID: 21775085 DOI: 10.1016/j.mri.2011.05.007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
71 Fowler KJ, Kaur H, Cash BD, Feig BW, Gage KL, Garcia EM, Hara AK, Herman JM, Kim DH, Lambert DL, Levy AD, Peterson CM, Scheirey CD, Small W Jr, Smith MP, Lalani T, Carucci LR; Expert Panel on Gastrointestinal Imaging:. ACR Appropriateness Criteria® Pretreatment Staging of Colorectal Cancer. J Am Coll Radiol 2017;14:S234-44. [PMID: 28473079 DOI: 10.1016/j.jacr.2017.02.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
72 Gotra A, Sivakumaran L, Chartrand G, Vu KN, Vandenbroucke-Menu F, Kauffmann C, Kadoury S, Gallix B, de Guise JA, Tang A. Liver segmentation: indications, techniques and future directions. Insights Imaging 2017;8:377-92. [PMID: 28616760 DOI: 10.1007/s13244-017-0558-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 33] [Article Influence: 10.2] [Reference Citation Analysis]
73 Renzulli M, Clemente A, Spinelli D, Ierardi AM, Marasco G, Farina D, Brocchi S, Ravaioli M, Pettinari I, Cescon M, Reginelli A, Cappabianca S, Carrafiello G, Golfieri R. Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging? Cancers (Basel) 2020;12:E1402. [PMID: 32485933 DOI: 10.3390/cancers12061402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
74 Suh CH, Kim KW, Park SH, Kim SY, Woo D, Shin S, Pyo J, Shinagare AB, Ramaiya NH, Lim Y. Performing Gadoxetic Acid–Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis. American Journal of Roentgenology 2018;210:W63-9. [DOI: 10.2214/ajr.17.18300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Shim JH, Han S, Shin YM, Lee YJ, Lee SG, Kim KM, Lim YS, Lee HC. Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma. J Magn Reson Imaging 2015;41:1115-23. [PMID: 24841479 DOI: 10.1002/jmri.24660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
76 Polanec SH, Bickel H, Baltzer PA, Thurner P, Gittler F, Hodge JC, Bashir MR, Ba-ssalamah A. Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback?: How to Minimize Gadoxetic Acid Artifacts. J Magn Reson Imaging 2017;46:1107-14. [DOI: 10.1002/jmri.25657] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
77 Endrikat J, Schwenke C, Vogtlaender K, Dohannish S, Breuer J. Safety profile of gadoxetate disodium in elderly patients (≥65 years). Acta Radiol 2018;59:81-8. [PMID: 28372493 DOI: 10.1177/0284185117700673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46:556-566. [PMID: 21623212 DOI: 10.1097/rli.0b013e31821a218a] [Cited by in Crossref: 69] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
79 Raman SS, Leary C, Bluemke DA, Amendola M, Sahani D, McTavish JD, Brody J, Outwater E, Mitchell D, Sheafor DH. Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr. 2010;34:163-172. [PMID: 20351497 DOI: 10.1097/rct.0b013e3181c89d87] [Cited by in Crossref: 50] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
80 Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2009;192:1675-1681. [PMID: 19457834 DOI: 10.2214/ajr.08.1262] [Cited by in Crossref: 243] [Cited by in F6Publishing: 89] [Article Influence: 18.7] [Reference Citation Analysis]
81 Thompson MJ, Hardy V, Zigman Suchsland M, Devine B, Kurth D, Chou R, Haines GR, Jarvik JG. A Secondary Analysis to Identify Patient-Centered Outcomes in the ACR’s Appropriateness Criteria. Journal of the American College of Radiology 2019;16:1645-55. [DOI: 10.1016/j.jacr.2019.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Saito K, Moriyasu F, Sugimoto K, Nishio R, Saguchi T, Nagao T, Taira J, Akata S, Tokuuye K. Diagnostic efficacy of gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodule. World J Gastroenterol 2011; 17(30): 3503-3509 [PMID: 21941417 DOI: 10.3748/wjg.v17.i30.3503] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
83 Riffel P, Schoenberg SO, Krammer J. [Importance of diffusion imaging in liver metastases]. Radiologe 2017;57:382-91. [PMID: 28283730 DOI: 10.1007/s00117-017-0233-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Rief M, Huppertz A, Asbach P, Franiel T, Schwenke C, Hamm B, Taupitz M, Wagner M. Manganese-Based Oral Contrast Agent for Liver Magnetic Resonance Imaging: Evaluation of the Time Course and Dose Response of Liver Signal Intensity Enhancement. Investigative Radiology 2010;45:565-71. [DOI: 10.1097/rli.0b013e3181e9e120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
85 Kitajima K, Murakami K, Yamasaki E, Domeki Y, Tsubaki M, Sunagawa M, Kaji Y, Suganuma N, Sugimura K. Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT. Eur J Nucl Med Mol Imaging. 2009;36:1388-1396. [PMID: 19370346 DOI: 10.1007/s00259-009-1081-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
86 Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol. 2009;193:W490-W496. [PMID: 19933623 DOI: 10.2214/ajr.08.1732] [Cited by in Crossref: 103] [Cited by in F6Publishing: 28] [Article Influence: 8.6] [Reference Citation Analysis]
87 Kantarci M, Pirimoglu B, Ogul H, Bayraktutan U, Eren S, Aydinli B, Ozturk G, Karaca L. Can biliary–cyst communication be predicted by Gd-EOB-DTPA-enhanced MR cholangiography before treatment for hepatic hydatid disease? Clinical Radiology 2014;69:52-8. [DOI: 10.1016/j.crad.2013.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
88 Jin YJ, Nah SY, Lee JW, Lee JI, Jeong S, Lee DH, Kim YS, Cho SG, Jeon YS. Utility of adding Primovist magnetic resonance imaging to analysis of hepatocellular carcinoma by liver dynamic computed tomography. Clin Gastroenterol Hepatol 2013;11:187-92. [PMID: 23142203 DOI: 10.1016/j.cgh.2012.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
89 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 45.0] [Reference Citation Analysis]
90 Balli H, Aksungur E, Khalatai B, Aikimbaev K. Super-Selective Transarterial Chemoembolization with Doxorubicin-Loaded Drug-Eluting Beads Sized Below and Above 100 Microns in Hepatocellular Carcinoma: A Comparative Study. J Belg Soc Radiol 2019;103:47. [PMID: 31531413 DOI: 10.5334/jbsr.1841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Groom K, Penna M, Arul D, Steward M, Leonard P, Wilson J. Capecitabine-related liver lesions: sinusoidal dilatation mimicking liver metastasis. Clin Case Rep 2016;4:545-8. [PMID: 27398193 DOI: 10.1002/ccr3.539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Belgherbi A, Hadjidj I, Bessaid A. MORPHOLOGICAL SEGMENTATION OF THE KIDNEYS FROM ABDOMINAL CT IMAGES. J Mech Med Biol 2014;14:1450073. [DOI: 10.1142/s0219519414500730] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
93 Yu MH, Kim JH, Yoon J, Kim H, Chung JW, Han JK, Choi B. Role of C-Arm CT for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Diagnostic Performance and Predictive Value for Therapeutic Response Compared With Gadoxetic Acid–Enhanced MRI. American Journal of Roentgenology 2013;201:675-83. [DOI: 10.2214/ajr.12.10445] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
94 Donadon M, Torzilli G. Intraoperative ultrasound in patients with hepatocellular carcinoma: from daily practice to future trends. Liver Cancer 2013;2:16-24. [PMID: 24159592 DOI: 10.1159/000346421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
95 Kim KA, Kim M, Park M, Lim JS, Choi J, Hong H, Kim KW. Optimal T2-weighted MR Cholangiopancreatographic Images Can Be Obtained after Administration of Gadoxetic Acid. Radiology 2010;256:475-84. [DOI: 10.1148/radiol.10091774] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
96 Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K. Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 2011;21:2336-43. [DOI: 10.1007/s00330-011-2197-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
97 Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB; American Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12:289-299. [PMID: 20590901 DOI: 10.1111/j.1477-2574.2010.00181.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]
98 Jeong HT, Kim MJ, Chung YE, Choi JY, Park YN, Kim KW. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. AJR Am J Roentgenol. 2013;201:W603-W611. [PMID: 24059399 DOI: 10.2214/ajr.12.10262] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
99 Keller S, Chapiro J, Brangsch J, Reimann C, Collettini F, Sack I, Savic LJ, Hamm B, Goldberg SN, Makowski M. Quantitative MRI for Assessment of Treatment Outcomes in a Rabbit VX2 Hepatic Tumor Model. J Magn Reson Imaging 2020;52:668-85. [PMID: 31713973 DOI: 10.1002/jmri.26968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
100 Han K, Park SH, Kim KW, Kim HJ, Lee SS, Kim JC, Yu CS, Lim S, Joo Y, Kim AY, Ha HK. Use of Liver Magnetic Resonance Imaging After Standard Staging Abdominopelvic Computed Tomography to Evaluate Newly Diagnosed Colorectal Cancer Patients. Annals of Surgery 2015;261:480-6. [DOI: 10.1097/sla.0000000000000708] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
101 Chiorean L, Caraiani C, Radziņa M, Jedrzejczyk M, Schreiber-dietrich D, Dietrich CF. Vascular phases in imaging and their role in focal liver lesions assessment. CH 2016;62:299-326. [DOI: 10.3233/ch-151971] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
102 Endrikat JS, Dohanish S, Balzer T, Breuer JA. Safety of gadoxetate disodium: Results from the clinical phase II-III development program and postmarketing surveillance. J Magn Reson Imaging 2015;42:634-43. [PMID: 25643844 DOI: 10.1002/jmri.24838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
103 Shiozawa K, Matsui T, Murakami T, Watanabe M, Maetani I. Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound. Diagnostics (Basel) 2021;11:291. [PMID: 33673221 DOI: 10.3390/diagnostics11020291] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Nakamura Y, Toyota N, Date S, Oda S, Namimoto T, Yamashita Y, Beppu T, Awai K. Clinical significance of the transitional phase at gadoxetate disodium-enhanced hepatic MRI for the diagnosis of hepatocellular carcinoma: preliminary results. J Comput Assist Tomogr. 2011;35:723-727. [PMID: 22082543 DOI: 10.1097/rct.0b013e3182372c40] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
105 Jeong WK, Kim YK, Song KD, Choi D, Lim HK. The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase. Clin Mol Hepatol. 2013;19:360-366. [PMID: 24459639 DOI: 10.3350/cmh.2013.19.4.360] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
106 Channual S, Pahwa A, Lu DS, Raman SS. Enhancements in hepatobiliary imaging: the spectrum of gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid usages in hepatobiliary magnetic resonance imaging. Abdom Radiol (NY) 2016;41:1825-41. [PMID: 27225503 DOI: 10.1007/s00261-016-0767-y] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
107 Pandey P, Lewis H, Pandey A, Schmidt C, Dillhoff M, Kamel IR, Pawlik TM. Updates in hepatic oncology imaging. Surgical Oncology 2017;26:195-206. [DOI: 10.1016/j.suronc.2017.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
108 Böttcher J, Hansch A, Pfeil A, Schmidt P, Malich A, Schneeweiss A, Maurer MH, Streitparth F, Teichgräber UK, Renz DM. Detection and classification of different liver lesions: comparison of Gd-EOB-DTPA-enhanced MRI versus multiphasic spiral CT in a clinical single centre investigation. Eur J Radiol. 2013;82:1860-1869. [PMID: 23932636 DOI: 10.1016/j.ejrad.2013.06.013] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 3.8] [Reference Citation Analysis]
109 Karaosmanoglu AD, Onur MR, Ozmen MN, Akata D, Karcaaltincaba M. Magnetic Resonance Imaging of Liver Metastasis. Semin Ultrasound CT MR. 2016;37:533-548. [PMID: 27986172 DOI: 10.1053/j.sult.2016.08.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
110 Nakamura Y, Date S, Toyota N, Tani C, Honda Y, Komoto D, Tanitame K, Awai K. Effect of lapatinib on hepatic parenchymal enhancement on gadoxetate disodium (EOB)-enhanced MRI scans. J Comput Assist Tomogr 2011;35:351-2. [PMID: 21586929 DOI: 10.1097/RCT.0b013e31821a02aa] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
111 Malone D, Zech CJ, Ayuso C, Bartolozzi C, Jonas E, Tanimoto A; 1st International Primovist User Meeting Attendees. Magnetic resonance imaging of the liver: consensus statement from the 1st International Primovist User Meeting. Eur Radiol Suppl 2008;18:849-64. [DOI: 10.1007/s10406-008-0010-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
112 Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, Schreyer AG, Stroszczynski C, Wiggermann P. MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 2014;4:5621. [PMID: 25001391 DOI: 10.1038/srep05621] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
113 Korngold EK, Moreno C, Kim DH, Fowler KJ, Cash BD, Chang KJ, Gage KL, Gajjar AH, Garcia EM, Kambadakone AR, Liu PS, Macomber M, Marin D, Pietryga JA, Santillan CS, Weinstein S, Zreloff J, Carucci LR; Expert Panel on Gastrointestinal Imaging. ACR Appropriateness Criteria® Staging of Colorectal Cancer: 2021 Update. J Am Coll Radiol 2022;19:S208-22. [PMID: 35550803 DOI: 10.1016/j.jacr.2022.02.012] [Reference Citation Analysis]
114 Kobayashi T, Aikata H, Hatooka M, Morio K, Morio R, Kan H, Fujino H, Fukuhara T, Masaki K, Ohno A, Naeshiro N, Nakahara T, Honda Y, Murakami E, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Takahashi S, Chayama K. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma. Eur Radiol 2015;25:3272-81. [DOI: 10.1007/s00330-015-3725-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
115 Hwang J, Kim YK, Park MJ, Lee MH, Kim SH, Lee WJ, Rhim HC. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI. J Magn Reson Imaging. 2012;36:881-889. [PMID: 22730271 DOI: 10.1002/jmri.23728] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
116 Jia J, Puls D, Oswald S, Jedlitschky G, Kühn JP, Weitschies W, Hosten N, Siegmund W, Keiser M. Characterization of the Intestinal and Hepatic Uptake/Efflux Transport of the Magnetic Resonance Imaging Contrast Agent Gadolinium-Ethoxylbenzyl-Diethylenetriamine-Pentaacetic Acid: . Investigative Radiology 2014;49:78-86. [DOI: 10.1097/rli.0b013e3182a70043] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
117 Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J. Magnetic Resonance Imaging of Liver Metastases: Experimental Comparison of Anionic and Conventional Superparamagnetic Iron Oxide Particles With a Hepatobiliary Contrast Medium During Dynamic and Uptake Phases: . Investigative Radiology 2008;43:496-503. [DOI: 10.1097/rli.0b013e31816f1be1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
118 Chiorean L, Cui XW, Tannapfel A, Franke D, Stenzel M, Kosiak W, Schreiber-Dietrich D, Jüngert J, Chang JM, Dietrich CF. Benign liver tumors in pediatric patients - Review with emphasis on imaging features. World J Gastroenterol 2015; 21(28): 8541-8561 [PMID: 26229397 DOI: 10.3748/wjg.v21.i28.8541] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
119 Fidler J, Hough D. Hepatocyte-specific magnetic resonance imaging contrast agents. Hepatology 2011;53:678-82. [PMID: 21274888 DOI: 10.1002/hep.24158] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
120 Wang JH, Chen TY, Ou HY, Wang CC, Liu YW, Hung CH, Chen CH, Kuo CH, Hu TH, Cheng YF. Clinical Impact of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging on Hepatoma Management: A Prospective Study. Dig Dis Sci. 2016;61:1197-1205. [PMID: 26668057 DOI: 10.1007/s10620-015-3989-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
121 Schelhorn J, Best J, Dechêne A, Göbel T, Bertram S, Lauenstein T, Kinner S. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading. Acta Radiol 2016;57:932-8. [PMID: 26586852 DOI: 10.1177/0284185115616293] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
122 Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 2010;255:459-466. [PMID: 20413759 DOI: 10.1148/radiol.10091388] [Cited by in Crossref: 259] [Cited by in F6Publishing: 239] [Article Influence: 21.6] [Reference Citation Analysis]
123 Van Beers BE, Pastor CM, Hussain HK. Primovist, Eovist: what to expect? J Hepatol 2012;57:421-9. [PMID: 22504332 DOI: 10.1016/j.jhep.2012.01.031] [Cited by in Crossref: 245] [Cited by in F6Publishing: 207] [Article Influence: 24.5] [Reference Citation Analysis]
124 Haimerl M, Utpatel K, Götz A, Zeman F, Fellner C, Nickel D, Luerken L, Brennfleck F, Stroszczynski C, Scheiter A, Verloh N. Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade. Sci Rep 2021;11:22991. [PMID: 34837039 DOI: 10.1038/s41598-021-02499-2] [Reference Citation Analysis]
125 Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. World J Gastroenterol 2012; 18(43): 6269-6276 [PMID: 23180948 DOI: 10.3748/wjg.v18.i43.6269] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
126 Fujinaga Y, Ueda H, Kitou Y, Tsukahara Y, Sugiyama Y, Kadoya M. Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo. Jpn J Radiol 2013;31:166-71. [PMID: 23179788 DOI: 10.1007/s11604-012-0162-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
127 Jeon I, Cho ES, Kim JH, Kim DJ, Yu JS, Chung JJ. Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30° Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis. PLoS One 2016;11:e0167701. [PMID: 27936106 DOI: 10.1371/journal.pone.0167701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
128 Nakamura S, Awai K, Utsunomiya D, Namimoto T, Nakaura T, Morita K, Yamashita Y. Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement? Jpn J Radiol. 2012;30:25-33. [PMID: 22160649 DOI: 10.1007/s11604-011-0003-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
129 Cho ES, Yu JS, Park AY, Woo S, Kim JH, Chung JJ. Feasibility of 5-minute delayed transition phase imaging with 30° flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver, compared with 20-minute delayed hepatocyte phase MRI with standard 10° flip angle. AJR Am J Roentgenol. 2015;204:69-75. [PMID: 25539239 DOI: 10.2214/ajr.13.11903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 van Kessel CS, Veldhuis WB, van den Bosch MA, van Leeuwen MS. MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation. Eur Radiol. 2012;22:2153-2160. [PMID: 22645040 DOI: 10.1007/s00330-012-2486-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
131 Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS. Preoperative evaluation of colorectal liver metastases: comparison of gadopentetate dimeglumine and gadoxetic-acid-enhanced 1.5-T MRI. Clin Imaging 2014;38:273-8. [PMID: 24559747 DOI: 10.1016/j.clinimag.2013.12.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
132 Maurea S, Mainenti PP, Tambasco A, Imbriaco M, Mollica C, Laccetti E, Camera L, Liuzzi R, Salvatore M. Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014;4:181-189. [PMID: 24914419 DOI: 10.3978/j.issn.2223-4292.2014.01.02] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
133 Ringe KI, Husarik DB, Sirlin CB, Merkle EM. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol. 2010;195:13-28. [PMID: 20566794 DOI: 10.2214/ajr.10.4392] [Cited by in Crossref: 250] [Cited by in F6Publishing: 67] [Article Influence: 20.8] [Reference Citation Analysis]
134 Fowler KJ, Saad NE, Linehan D. Imaging Approach to Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer. Surgical Oncology Clinics of North America 2015;24:19-40. [DOI: 10.1016/j.soc.2014.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
135 Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 2012;85:29-36. [PMID: 21123305 DOI: 10.1259/bjr/12929687] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
136 Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Kitamura T, Amemiya F, Enomoto N, Matsuda M, Asakawa M, Fujii H, Araki T. Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver Disease: . Investigative Radiology 2011;46:141-5. [DOI: 10.1097/rli.0b013e3181f9c487] [Cited by in Crossref: 69] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
137 Tsuda N, Harada K, Matsui O. Effect of change in transporter expression on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging during hepatocarcinogenesis in rats. J Gastroenterol Hepatol. 2011;26:568-576. [PMID: 21332553 DOI: 10.1111/j.1440-1746.2010.06494.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
138 Donati OF, Fischer MA, Chuck N, Hunziker R, Weishaupt D, Reiner CS. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases. Eur J Radiol. 2013;82:822-828. [PMID: 23287713 DOI: 10.1016/j.ejrad.2012.12.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
139 Rosenberg C, Jahn A, Pickartz T, Wahnschaffe U, Patrzyk M, Hosten N. Gd-EOB-DTPA-enhanced MR guidance in thermal ablation of liver malignancies. PLoS One 2014;9:e109217. [PMID: 25541950 DOI: 10.1371/journal.pone.0109217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
140 Park G, Kim YK, Kim CS, Yu HC, Hwang SB. Diagnostic efficacy of gadoxetic acid-enhanced MRI in the detection of hepatocellular carcinomas: comparison with gadopentetate dimeglumine. Br J Radiol 2010;83:1010-6. [PMID: 20682591 DOI: 10.1259/bjr/66686028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
141 Lee MH, Kim SH, Park MJ, Park CK, Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. AJR Am J Roentgenol. 2011;197:W868-W875. [PMID: 22021534 DOI: 10.2214/ajr.10.6237] [Cited by in Crossref: 96] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
142 Caraiani CN, Dan M, Fenesan DI, Badea R. Description of focal liver lesions with Gd-EOB-DTPA enhanced MRI. Clujul Med 2015;88:438-48. [PMID: 26733231 DOI: 10.15386/cjmed-414] [Reference Citation Analysis]
143 Haimerl M, Wächtler M, Platzek I, Müller-Wille R, Niessen C, Hoffstetter P, Schreyer AG, Stroszczynski C, Wiggermann P. Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions. BMC Med Imaging 2013;13:41. [PMID: 24289722 DOI: 10.1186/1471-2342-13-41] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
144 Tamada T, Ito K, Ueki A, Kanki A, Higaki A, Higashi H, Yamamoto A. Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver. J Magn Reson Imaging. 2012;35:852-858. [PMID: 22127980 DOI: 10.1002/jmri.23514] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
145 Algarni AA, Alshuhri AH, Alonazi MM, Mourad MM, Bramhall SR. Focal liver lesions found incidentally. World J Hepatol 2016; 8(9): 446-451 [PMID: 27028805 DOI: 10.4254/wjh.v8.i9.446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
146 van Kessel CS, Buckens CF, van den Bosch MA, van Leeuwen MS, van Hillegersberg R, Verkooijen HM. Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol. 2012;19:2805-2813. [PMID: 22396005 DOI: 10.1245/s10434-012-2300-z] [Cited by in Crossref: 109] [Cited by in F6Publishing: 82] [Article Influence: 10.9] [Reference Citation Analysis]
147 Fernandez-de-manuel L, Wollny G, Kybic J, Jimenez-carretero D, Tellado JM, Ramon E, Desco M, Santos A, Pascau J, Ledesma-carbayo MJ. Organ-focused mutual information for nonrigid multimodal registration of liver CT and Gd–EOB–DTPA-enhanced MRI. Medical Image Analysis 2014;18:22-35. [DOI: 10.1016/j.media.2013.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
148 Matsui O, Gabata T, Kobayashi S. Optimal imaging of hepatic mass lesions. J Gastroenterol Hepatol 2008;23:1466-8. [PMID: 19120844 DOI: 10.1111/j.1440-1746.2008.05647.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Purysko AS, Remer EM, Veniero JC. Focal liver lesion detection and characterization with GD-EOB-DTPA. Clin Radiol. 2011;66:673-684. [PMID: 21524416 DOI: 10.1016/j.crad.2011.01.014] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
150 Schima W, Koh D, Baron R. Focal Liver Lesions. In: Hodler J, Kubik-huch RA, von Schulthess GK, editors. Diseases of the Abdomen and Pelvis 2018-2021. Cham: Springer International Publishing; 2018. pp. 173-96. [DOI: 10.1007/978-3-319-75019-4_17] [Reference Citation Analysis]
151 Veres DS, Máthé D, Futó I, Horváth I, Balázs Á, Karlinger K, Szigeti K. Quantitative Liver Lesion Volume Determination by Nanoparticle-Based SPECT. Mol Imaging Biol 2014;16:167-72. [DOI: 10.1007/s11307-013-0679-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
152 Kitajima K, Yoshikawa T, Seo Y, Ohno Y, Yano Y, Miki A, Kanda T, Kanata N, Azuma T, Sugimura K. A case of Budd-Chiari syndrome: Gd-EOB-DTPA-enhanced MR findings. Magn Reson Imaging. 2011;29:579-583. [PMID: 21216550 DOI: 10.1016/j.mri.2010.10.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
153 Yamada T, Obata A, Kashiwagi Y, Rokugawa T, Matsushima S, Hamada T, Watabe H, Abe K. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Magn Reson Imaging 2016;34:724-9. [PMID: 26979540 DOI: 10.1016/j.mri.2016.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
154 Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A. "Vanishing liver metastases"-A real challenge for liver surgeons. Hepatobiliary Surg Nutr. 2014;3:295-302. [PMID: 25392841 DOI: 10.3978/j.issn.2304-3881.2014.09.13] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
155 Shengping H, Mingliang W, Zhiyuan W, Xuesong Z, Fei M. Gemstone Spectral Monochromatic CT Imaging: Detection and Classification of Focal Liver Lesions in Patients with Pancreatic Cancer. Euroasian Journal of Hepato-Gastroenterology 2011;1:77-82. [DOI: 10.5005/jp-journals-10018-1017] [Reference Citation Analysis]
156 Knobloch G, Colgan T, Wang X, Woo KM, Schubert T, Reeder SB. Combined gadoxetic acid and gadobenate dimeglumine enhanced liver MRI: a parameter optimization study. Abdom Radiol (NY) 2020;45:220-31. [PMID: 31606763 DOI: 10.1007/s00261-019-02265-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Chung S, Kim M, Choi J, Hong H. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver. J Magn Reson Imaging 2010;31:365-72. [DOI: 10.1002/jmri.22057] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
158 Fahlenkamp UL, Engel G, Adams LC, Böker SM, Huynh Anh M, Wagner M, Hamm B, Makowski MR. Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging. PLoS One 2019;14:e0213408. [PMID: 30840710 DOI: 10.1371/journal.pone.0213408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
159 Caserta MP, Sakala M, Shen P, Gorden L, Wile G. Presurgical planning for hepatobiliary malignancies: clinical and imaging considerations. Magn Reson Imaging Clin N Am 2014;22:447-65. [PMID: 25086939 DOI: 10.1016/j.mric.2014.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Fujinaga Y, Ohya A, Tokoro H, Yamada A, Ueda K, Ueda H, Kitou Y, Adachi Y, Shiobara A, Tamaru N. Radial volumetric imaging breath-hold examination (VIBE) with k-space weighted image contrast (KWIC) for dynamic gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI of the liver: advantages over Cartesian VIBE in the arterial phase. Eur Radiol. 2014;24:1290-1299. [PMID: 24633374 DOI: 10.1007/s00330-014-3122-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
161 Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T. Fibrosis imaging: Current concepts and future directions. Adv Drug Deliv Rev 2017;121:9-26. [PMID: 29108860 DOI: 10.1016/j.addr.2017.10.013] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 14.6] [Reference Citation Analysis]
162 Chanyaputhipong J, Low SC, Chow PK. Gadoxetate Acid-Enhanced MR Imaging for HCC: A Review for Clinicians. Int J Hepatol. 2011;2011:489342. [PMID: 21994860 DOI: 10.4061/2011/489342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
163 Leander P, Golman K, Månsson S, Höglund P. Orally Administered Manganese With and Without Ascorbic Acid as a Liver-Specific Contrast Agent and Bowel Marker for Magnetic Resonance Imaging: Phase I Clinical Trial Assessing Efficacy and Safety. Investigative Radiology 2010;45:559-64. [DOI: 10.1097/rli.0b013e3181e960ab] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
164 Ngu S, Lebron-Zapata L, Pomeranz C, Katz S, Gerst S, Zheng J, Moskowitz C, Do RK. Inter-observer agreement on the assessment of relative liver lesion signal intensity on hepatobiliary phase imaging with gadoxetate (Gd-EOB-DTPA). Abdom Radiol (NY) 2016;41:50-5. [PMID: 26830611 DOI: 10.1007/s00261-015-0609-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
165 Zeng MS, Ye HY, Guo L, Peng WJ, Lu JP, Teng GJ, Huan Y, Li P, Xu JR, Liang CH. Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study. Hepatobiliary Pancreat Dis Int. 2013;12:607-616. [PMID: 24322746 DOI: 10.1016/s1499-3872(13)60096-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
166 Rhee H, Kim MJ, Park MS, Kim KA. Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol 2012;85:e837-44. [PMID: 22553295 DOI: 10.1259/bjr/13212920] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
167 Zech CJ, Korpraphong P, Huppertz A, Denecke T, Kim MJ, Tanomkiat W, Jonas E, Ba-Ssalamah A; VALUE study group. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Br J Surg. 2014;101:613-621. [PMID: 24652690 DOI: 10.1002/bjs.9465] [Cited by in Crossref: 82] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
168 Motosugi U, Ichikawa T, Tominaga L, Sou H, Sano K, Ichikawa S, Araki T. Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol. 2009;19:2623-2629. [PMID: 19471935 DOI: 10.1007/s00330-009-1467-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
169 Zheng J, Zhen M, Wang C, Shu C. Recent Progress of Molecular Imaging Probes Based on Gadofullerenes. Chinese Journal of Analytical Chemistry 2012;40:1607-15. [DOI: 10.1016/s1872-2040(11)60581-1] [Cited by in Crossref: 19] [Article Influence: 1.9] [Reference Citation Analysis]
170 Kitajima K, Murakami K, Kanegae K, Tamaki N, Kaneta T, Fukuda H, Nakajima K, Fujii H, Tateishi U, Kubota K, Suga T, Nakamoto Y. Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter study. Ann Nucl Med 2009;23:709-15. [DOI: 10.1007/s12149-009-0297-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
171 Lafaro KJ, Roumanis P, Demirjian AN, Lall C, Imagawa DK. Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective! Int J Hepatol 2013;2013:572307. [PMID: 23653860 DOI: 10.1155/2013/572307] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
172 Galea N, Cantisani V, Taouli B. Liver lesion detection and characterization: role of diffusion-weighted imaging. J Magn Reson Imaging 2013;37:1260-76. [PMID: 23712841 DOI: 10.1002/jmri.23947] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
173 Ichikawa T, Sano K, Morisaka H. Diagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current Consensus. Liver Cancer 2014;3:97-107. [PMID: 24945000 DOI: 10.1159/000343865] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 6.1] [Reference Citation Analysis]
174 Holzapfel K, Eiber MJ, Fingerle AA, Bruegel M, Rummeny EJ, Gaa J. Detection, classification, and characterization of focal liver lesions: Value of diffusion-weighted MR imaging, gadoxetic acid-enhanced MR imaging and the combination of both methods. Abdom Imaging 2012;37:74-82. [DOI: 10.1007/s00261-011-9758-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
175 Moon M, Thomas RG, Heo S, Park M, Bae WK, Heo SH, Yim NY, Jeong YY. A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging. Mol Imaging Biol 2015;17:497-503. [DOI: 10.1007/s11307-014-0819-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
176 Baltzer PA, Schelhorn J, Benndorf M, Dietzel M, Kaiser WA. Diagnosis of focal liver lesions suspected of metastases by diffusion-weighted imaging (DWI): systematic comparison favors free-breathing technique. Clinical Imaging 2013;37:97-103. [DOI: 10.1016/j.clinimag.2012.02.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
177 Ito T, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Aramaki T, Endo M, Uesaka K. The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 2017;17:451-6. [DOI: 10.1016/j.pan.2017.03.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
178 Sofue K, Tsurusaki M, Murakami T, Onoe S, Tokue H, Shibamoto K, Arai Y, Sugimura K. Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases? Eur Radiol. 2014;24:2532-2539. [PMID: 24865698 DOI: 10.1007/s00330-014-3233-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
179 Jhaveri KS, Fischer SE, Hosseini-Nik H, Sreeharsha B, Menezes RJ, Gallinger S, Moulton CE. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. HPB (Oxford) 2017;19:992-1000. [PMID: 28760631 DOI: 10.1016/j.hpb.2017.06.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
180 Chau GY. Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome. World J Gastroenterol 2014; 20(35): 12473-12484 [PMID: 25253947 DOI: 10.3748/wjg.v20.i35.12473] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
181 Yamada T, Kashiwagi Y, Rokugawa T, Kato H, Konishi H, Hamada T, Nagai R, Masago Y, Itoh M, Suganami T, Ogawa Y, Abe K. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis. Magn Reson Imaging 2019;57:210-7. [PMID: 30465867 DOI: 10.1016/j.mri.2018.11.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
182 Lauenstein T, Ramirez-Garrido F, Kim YH, Rha SE, Ricke J, Phongkitkarun S, Boettcher J, Gupta RT, Korpraphong P, Tanomkiat W, Furtner J, Liu PS, Henry M, Endrikat J. Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study. Invest Radiol 2015;50:416-22. [PMID: 25756684 DOI: 10.1097/RLI.0000000000000145] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
183 Cieszanowski A, Podgórska J, Rosiak G, Maj E, Grudziński IP, Kaczyński B, Szeszkowski W, Milczarek K, Rowiński O. Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC). Pol J Radiol 2016;81:103-9. [PMID: 27026795 DOI: 10.12659/PJR.895701] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
184 Kühn JP, Langner S, Hegenscheid K, Evert M, Kickhefel A, Hosten N, Puls R. Magnetic resonance-guided upper abdominal biopsies in a high-field wide-bore 3-T MRI system: feasibility, handling, and needle artefacts. Eur Radiol 2010;20:2414-21. [PMID: 20503050 DOI: 10.1007/s00330-010-1809-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
185 Zech CJ, Justo N, Lang A, Ba-Ssalamah A, Kim MJ, Rinde H, Jonas E. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial. Eur Radiol 2016;26:4121-30. [PMID: 26905871 DOI: 10.1007/s00330-016-4271-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
186 Haimerl M, Wächtler M, Zeman F, Verloh N, Platzek I, Schreyer AG, Stroszczynski C, Wiggermann P. Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. PLoS One 2014;9:e100315. [PMID: 24950259 DOI: 10.1371/journal.pone.0100315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
187 Asbach P, Warmuth C, Stemmer A, Rief M, Huppertz A, Hamm B, Taupitz M, Klessen C. High Spatial Resolution T1-Weighted MR Imaging of Liver and Biliary Tract During Uptake Phase of a Hepatocyte-Specific Contrast Medium: . Investigative Radiology 2008;43:809-15. [DOI: 10.1097/rli.0b013e318186242b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
188 Donati OF, Hunziker R, Fischer MA, Raptis DA, Breitenstein S, Patak MA. MRI for characterization of primary tumors in the non-cirrhotic liver: Added value of Gd-EOB-DTPA enhanced hepatospecific phase. European Journal of Radiology 2014;83:1074-9. [DOI: 10.1016/j.ejrad.2014.03.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
189 Ishikawa T, Ohno E, Mizutani Y, Iida T, Koya T, Sasaki Y, Ogawa H, Kinoshita F, Hirooka Y, Kawashima H. Comparison of contrast-enhanced transabdominal ultrasonography following endoscopic ultrasonography with GD-EOB-DTPA-enhanced MRI for the sequential diagnosis of liver metastasis in patients with pancreatic cancer. J Hepatobiliary Pancreat Sci 2021. [PMID: 34878726 DOI: 10.1002/jhbp.1097] [Reference Citation Analysis]
190 Fischbach F, Lohfink K, Gaffke G, Wybranski C, Mohnike K, Wonneberger U, Pech M, Jungnickel K, Ricke J, Strach K. Magnetic Resonance–Guided Freehand Radiofrequency Ablation of Malignant Liver Lesions: A New Simplified and Time-Efficient Approach Using an Interactive Open Magnetic Resonance Scan Platform and Hepatocyte-Specific Contrast Agent. Investigative Radiology 2013;48:422-8. [DOI: 10.1097/rli.0b013e3182803dae] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
191 Chen BB, Murakami T, Shih TT, Sakamoto M, Matsui O, Choi BI, Kim MJ, Lee JM, Yang RJ, Zeng MS, Chen RC, Liang JD. Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014). Liver Cancer 2015;4:215-27. [PMID: 26734577 DOI: 10.1159/000367742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
192 Albrecht MH, Wichmann JL, Müller C, Schreckenbach T, Sakthibalan S, Hammerstingl R, Bechstein WO, Zangos S, Ackermann H, Vogl TJ. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation. Eur J Radiol 2014;83:1752-8. [PMID: 25082480 DOI: 10.1016/j.ejrad.2014.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
193 Endrikat J, Kim SY, Sakaguchi T, Dohanish S, Breuer J. Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients. Acta Radiol 2016;57:1326-33. [PMID: 26048848 DOI: 10.1177/0284185115588126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
194 Cieszanowski A, Anysz-Grodzicka A, Szeszkowski W, Kaczynski B, Maj E, Gornicka B, Grodzicki M, Grudzinski IP, Stadnik A, Krawczyk M. Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times. Eur Radiol. 2012;22:2514-2524. [PMID: 22699872 DOI: 10.1007/s00330-012-2519-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
195 Kim HD, Lim YS, Han S, An J, Kim GA, Kim SY, Lee SJ, Won HJ, Byun JH. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 2015;148:1371-1382. [PMID: 25733098 DOI: 10.1053/j.gastro.2015.02.051] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 9.7] [Reference Citation Analysis]
196 Kim SY, An J, Lim YS, Han S, Lee JY, Byun JH, Won HJ, Lee SJ, Lee HC, Lee YS. MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma. JAMA Oncol. 2017;3:456-463. [PMID: 27657493 DOI: 10.1001/jamaoncol.2016.3147] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 22.6] [Reference Citation Analysis]
197 Bhayana R, Baliyan V, Kordbacheh H, Kambadakone A. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns. Eur Radiol 2021;31:1359-66. [PMID: 32886204 DOI: 10.1007/s00330-020-07228-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 Schelhorn J, Best J, Reinboldt MP, Dechêne A, Gerken G, Ruhlmann M, Lauenstein TC, Antoch G, Kinner S. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI: DWI in HCC Response Evaluation After RE. J Magn Reson Imaging 2015;42:818-27. [DOI: 10.1002/jmri.24827] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
199 Ham JH, Yu JS, Choi JM, Cho ES, Kim JH, Chung JJ. Corona enhancement can substitute enhancing capsule in the imaging diagnosis of small (≤ 3 cm) HCCs on gadoxetic acid-enhanced MRI. Eur Radiol 2021. [PMID: 33891153 DOI: 10.1007/s00330-021-07911-z] [Reference Citation Analysis]
200 Quaia E. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound. Abdom Imaging 2012;37:580-90. [DOI: 10.1007/s00261-011-9788-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
201 Baek KA, Kim SS, Shin HC, Hwang JA, Choi SY, Lee WH, Park CH, Lee HN, Heo NH. Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout? Abdom Radiol (NY) 2020;45:2705-16. [PMID: 32382820 DOI: 10.1007/s00261-020-02553-z] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Rhee H, Kim MJ, Park YN, Choi JS, Kim KS. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria. J Magn Reson Imaging. 2012;35:393-398. [PMID: 21990116 DOI: 10.1002/jmri.22828] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
203 Löwenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, Pech M, Kropf S, Ricke J, Dudeck O. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 2011;21:832-40. [DOI: 10.1007/s00330-010-1977-2] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 8.5] [Reference Citation Analysis]
204 Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol. 2010;45:133-141. [PMID: 20098330 DOI: 10.1097/rli.0b013e3181caea5b] [Cited by in Crossref: 164] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
205 Choi SH, Byun JH, Kwon H, Ha HI, Lee SJ, Kim SY, Won HJ, Kim P. The Usefulness of Gadoxetic Acid-Enhanced Dynamic Magnetic Resonance Imaging in Hepatocellular Carcinoma: Toward Improved Staging. Ann Surg Oncol 2015;22:819-25. [DOI: 10.1245/s10434-014-4074-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
206 Felsted AE, Shi Y, Masand PM, Nuchtern JG, Goss JA, Vasudevan SA. Intraoperative ultrasound for liver tumor resection in children. J Surg Res 2015;198:418-23. [PMID: 25940155 DOI: 10.1016/j.jss.2015.03.087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
207 Eiber M, Fingerle AA, Brügel M, Gaa J, Rummeny EJ, Holzapfel K. Detection and classification of focal liver lesions in patients with colorectal cancer: Retrospective comparison of diffusion-weighted MR imaging and multi-slice CT. European Journal of Radiology 2012;81:683-91. [DOI: 10.1016/j.ejrad.2011.01.072] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
208 Beiderwellen K, Gomez B, Buchbender C, Hartung V, Poeppel TD, Nensa F, Kuehl H, Bockisch A, Lauenstein TC. Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI. Eur J Radiol 2013;82:e669-75. [PMID: 24011443 DOI: 10.1016/j.ejrad.2013.07.027] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
209 Scali EP, Walshe T, Tiwari HA, Harris AC, Chang SD. A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine. Can Assoc Radiol J 2017;68:293-307. [PMID: 28583364 DOI: 10.1016/j.carj.2016.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
210 Fülöp A, Szijártó A, Harsányi L, Budai A, Pekli D, Korsós D, Horváth I, Kovács N, Karlinger K, Máthé D, Szigeti K. Demonstration of metabolic and cellular effects of portal vein ligation using multi-modal PET/MRI measurements in healthy rat liver. PLoS One 2014;9:e90760. [PMID: 24599299 DOI: 10.1371/journal.pone.0090760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
211 Jhaveri K, Cleary S, Audet P, Balaa F, Bhayana D, Burak K, Chang S, Dixon E, Haider M, Molinari M, Reinhold C, Sherman M. Consensus Statements From a Multidisciplinary Expert Panel on the Utilization and Application of a Liver-Specific MRI Contrast Agent (Gadoxetic Acid). American Journal of Roentgenology 2015;204:498-509. [DOI: 10.2214/ajr.13.12399] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 8.1] [Reference Citation Analysis]
212 Bashir MR, Gupta RT, Davenport MS, Allen BC, Jaffe TA, Ho LM, Boll DT, Merkle EM. Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis? J Magn Reson Imaging. 2013;37:398-406. [PMID: 23011874 DOI: 10.1002/jmri.23818] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 7.3] [Reference Citation Analysis]
213 Borusewicz P, Stańczyk E, Kubiak K, Spużak J, Glińska-Suchocka K, Jankowski M, Sławuta P, Kubiak-Nowak D, Podgórski P. Magnetic resonance imaging of liver tumors using gadoxetic acid (Gd-EOB-DTPA) - pilot study. BMC Vet Res 2019;15:293. [PMID: 31412920 DOI: 10.1186/s12917-019-2038-y] [Reference Citation Analysis]
214 Kim YK, Kim CS, Han YM, Park G. Detection of Small Hepatocellular Carcinoma: Can Gadoxetic Acid-Enhanced Magnetic Resonance Imaging Replace Combining Gadopentetate Dimeglumine-Enhanced and Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging? Investigative Radiology 2010;45:740-6. [DOI: 10.1097/rli.0b013e3181e943a7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
215 Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, Giovagnoni A. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010;31:19-31. [PMID: 20027569 DOI: 10.1002/jmri.22010] [Cited by in Crossref: 168] [Cited by in F6Publishing: 126] [Article Influence: 14.0] [Reference Citation Analysis]
216 Liang M, Zhao J, Xie B, Li C, Yin X, Cheng L, Wang J, Zhang L. MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function. Eur J Radiol. 2016;85:546-552. [PMID: 26860666 DOI: 10.1016/j.ejrad.2015.12.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
217 Nassif A, Jia J, Keiser M, Oswald S, Modess C, Nagel S, Weitschies W, Hosten N, Siegmund W, Kühn JP. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology 2012;264:741-50. [PMID: 22771883 DOI: 10.1148/radiol.12112061] [Cited by in Crossref: 99] [Cited by in F6Publishing: 90] [Article Influence: 9.9] [Reference Citation Analysis]
218 Wu CH, Lee YH, Liang PC, Hu RH, Shih TT, Ho MC. Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma. J Formos Med Assoc 2022:S0929-6646(21)00593-3. [PMID: 35033411 DOI: 10.1016/j.jfma.2021.12.026] [Reference Citation Analysis]
219 Yim SY, Park BJ, Um SH, Han NY, Sung DJ, Cho SB, Lee SH, Kim MJ, Jung JY, Kim JD, Seo YS, Kim DS, An H, Kim YH. Diagnostic performance of gadoxetic acid (Primovist)-enhanced MR imaging versus CT during hepatic arteriography and portography for small hypervascular hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e4903. [PMID: 27684824 DOI: 10.1097/MD.0000000000004903] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
220 Di Martino M, Di Miscio R, De Filippis G, Lombardo CV, Saba L, Geiger D, Catalano C. Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging. Abdom Imaging. 2013;38:1254-1262. [PMID: 23857505 DOI: 10.1007/s00261-013-0009-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
221 Kim B, Byun JH, Kim HJ, Won HJ, Kim SY, Shin YM, Kim PN. Enhancement patterns and pseudo-washout of hepatic haemangiomas on gadoxetate disodium-enhanced liver MRI. Eur Radiol 2016;26:191-8. [DOI: 10.1007/s00330-015-3798-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
222 Li M, Xin Y, Fu S, Liu Z, Li Y, Hu B, Chen S, Liang C, Lu L. Corona Enhancement and Mosaic Architecture for Prognosis and Selection Between of Liver Resection Versus Transcatheter Arterial Chemoembolization in Single Hepatocellular Carcinomas >5 cm Without Extrahepatic Metastases: An Imaging-Based Retrospective Study. Medicine (Baltimore) 2016;95:e2458. [PMID: 26765441 DOI: 10.1097/MD.0000000000002458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
223 Quaia E. The real capabilities of contrast-enhanced ultrasound in the characterization of solid focal liver lesions. Eur Radiol 2011;21:457-62. [DOI: 10.1007/s00330-010-2007-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
224 Komatsu N, Motosugi U, Maekawa S, Shindo K, Sakamoto M, Sato M, Tatsumi A, Miura M, Amemiya F, Nakayama Y, Inoue T, Fukasawa M, Uetake T, Ohtaka M, Sato T, Asahina Y, Kurosaki M, Izumi N, Ichikawa T, Araki T, Enomoto N. Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging: HCC risk assessment using EOB-enhanced MRI. Hepatol Res 2014;44:1339-46. [DOI: 10.1111/hepr.12309] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
225 Bajpai S, Kambadakone A, Guimaraes AR, Arellano RS, Gervais DA, Sahani D. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation. RadioGraphics 2015;35:1393-418. [DOI: 10.1148/rg.2015140281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
226 Di Martino M, De Filippis G, De Santis A, Geiger D, Del Monte M, Lombardo CV, Rossi M, Corradini SG, Mennini G, Catalano C. Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging. Eur Radiol 2013;23:887-96. [PMID: 23179521 DOI: 10.1007/s00330-012-2691-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
227 Lee SA, Lee CH, Jung WY, Lee J, Choi JW, Kim KA, Park CM. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience. Magn Reson Imaging. 2011;29:83-90. [PMID: 20832227 DOI: 10.1016/j.mri.2010.07.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
228 Kawada N, Ohkawa K, Tanaka S, Matsunaga T, Uehara H, Ioka T, Takano Y, Takakura R, Imanaka K, Tamai C. Improved diagnosis of well-differentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography. Hepatol Res. 2010;40:930-936. [PMID: 20887598 DOI: 10.1111/j.1872-034x.2010.00697.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
229 Fowler KJ, Linehan DC, Menias CO. Comment: Fancier and More Expensive Do Mean Better: An Argument for Computed Tomography Staging of Patients With Colorectal Liver Metastases. Ann Surg Oncol 2017;24:605-6. [PMID: 29168097 DOI: 10.1245/s10434-017-6167-x] [Reference Citation Analysis]
230 Ahn SJ, Kim M, Hong H, Ah Kim K, Song H. Distinguishing hemangiomas from malignant solid hepatic lesions: A comparison of heavily T2-weighted images obtained before and after administration of gadoxetic acid. J Magn Reson Imaging 2011;34:310-7. [DOI: 10.1002/jmri.22658] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
231 Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 2013; 19(45): 8357-8365 [PMID: 24363528 DOI: 10.3748/wjg.v19.i45.8357] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
232 Patel S, Cheek S, Osman H, Jeyarajah DR. MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”? J Gastrointest Surg 2014;18:2130-5. [DOI: 10.1007/s11605-014-2676-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
233 Kaseb AO, Abaza YM, Roses RE. Multidisciplinary management of hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:247-259. [PMID: 22941025 DOI: 10.1007/978-3-642-16037-0_16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
234 Tanaka M, Kishi Y, Esaki M, Nara S, Miyake M, Hiraoka N, Nagino M, Shimada K. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases. Ann Surg Oncol. 2016;23:3991-3998. [PMID: 27357179 DOI: 10.1245/s10434-016-5362-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
235 Kaur H, Hindman NM, Al-Refaie WB, Arif-Tiwari H, Cash BD, Chernyak V, Farrell J, Grajo JR, Horowitz JM, McNamara MM, Noto RB, Qayyum A, Lalani T, Kamel IR; Expert Panel on Gastrointestinal Imaging:. ACR Appropriateness Criteria® Suspected Liver Metastases. J Am Coll Radiol 2017;14:S314-25. [PMID: 28473088 DOI: 10.1016/j.jacr.2017.01.037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
236 Schima W, Kölblinger C, Ba-Ssalamah A. Non-invasive diagnosis of focal liver lesions: an individualized approach. Cancer Imaging 2012;12:365-72. [PMID: 23023267 DOI: 10.1102/1470-7330.2012.9025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
237 Kantarcı M, Pirimoglu B, Karabulut N, Bayraktutan U, Ogul H, Ozturk G, Aydinli B, Kizrak Y, Eren S, Yilmaz S. Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography. Eur Radiol 2013;23:2713-22. [PMID: 23695221 DOI: 10.1007/s00330-013-2880-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
238 Luetkens JA, Kupczyk PA, Doerner J, Fimmers R, Willinek WA, Schild HH, Kukuk GM. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol 2015;25:3207-13. [PMID: 25903709 DOI: 10.1007/s00330-015-3736-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
239 Grazioli L, Lee JM, Malfertheiner P, Zech CJ, Blomqvist L, Merkle EM. Consensus Report of the Third International Forum for Liver Magnetic Resonance Imaging: . Investigative Radiology 2010;45:S1-S10. [DOI: 10.1097/rli.0b013e3181fe7083] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
240 Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, Higashi H, Sone T. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80:e311-e316. [PMID: 21315529 DOI: 10.1016/j.ejrad.2011.01.020] [Cited by in Crossref: 118] [Cited by in F6Publishing: 100] [Article Influence: 10.7] [Reference Citation Analysis]
241 Deng H, Shang W, Lu G, Guo P, Ai T, Fang C, Tian J. Targeted and Multifunctional Technology for Identification between Hepatocellular Carcinoma and Liver Cirrhosis. ACS Appl Mater Interfaces 2019;11:14526-37. [PMID: 30776888 DOI: 10.1021/acsami.8b20600] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
242 Noda Y, Goshima S, Kajita K, Kawada H, Kawai N, Koyasu H, Matsuo M, Bae KT. Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers. Eur J Radiol 2016;85:2001-7. [PMID: 27776652 DOI: 10.1016/j.ejrad.2016.09.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
243 Onishi H, Kim T, Imai Y, Hori M, Nagano H, Nakaya Y, Tsuboyama T, Nakamoto A, Tatsumi M, Kumano S. Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT. Eur Radiol. 2012;22:845-854. [PMID: 22057248 DOI: 10.1007/s00330-011-2316-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
244 Reimer P, Vosshenrich R. Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent. Biologics 2010;4:199-212. [PMID: 20714357 DOI: 10.2147/btt.s6479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
245 Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. Acta Radiol 2012;53:830-8. [PMID: 22847903 DOI: 10.1258/ar.2012.120099] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
246 Kim HJ, Lee SS, Byun JH, Kim JC, Yu CS, Park SH, Kim AY, Ha HK. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Radiology. 2015;274:712-722. [PMID: 25286324 DOI: 10.1148/radiol.14140390] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
247 Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement. J Comput Assist Tomogr. 2010;34:182-186. [PMID: 20351500 DOI: 10.1097/rct.0b013e3181bc961b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
248 Kim JH, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW. The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e5666. [PMID: 28002336 DOI: 10.1097/MD.0000000000005666] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
249 Aramaki O, Takayama T, Higaki T, Nakayama H, Okubo T, Midorikawa Y, Moriguchi M. Preoperative diagnosis with versus without MRI in resection for hepatocellular carcinoma. Surgery 2015;158:1512-20. [PMID: 26206318 DOI: 10.1016/j.surg.2015.06.019] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
250 Kubota K, Tamura T, Aoyama N, Nogami M, Hamada N, Nishioka A, Ogawa Y. Correlation of liver parenchymal gadolinium-ethoxybenzyl diethylenetriaminepentaacetic acid enhancement and liver function in humans with hepatocellular carcinoma. Oncol Lett 2012;3:990-4. [PMID: 22783378 DOI: 10.3892/ol.2012.629] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
251 Ohno T, Isoda H, Furuta A, Arizono S, Yamashita R, Ono A, Togashi K. Usefulness of breath-hold inversion recovery-prepared T1-weighted two-dimensional gradient echo sequence for detection of hepatocellular carcinoma in Gd-EOB-DTPA-enhanced MR imaging. Clin Imaging 2016;40:997-1003. [PMID: 27295329 DOI: 10.1016/j.clinimag.2016.05.002] [Reference Citation Analysis]
252 Lee SW, Cha SH, Chung HH, Kim KH, Yeom SK, Seo BK, Je BK, Kim BH. Functional magnetic resonance cholangiography with Gd-EOB-DTPA: a study in healthy volunteers. Magn Reson Imaging 2014;32:385-91. [PMID: 24529920 DOI: 10.1016/j.mri.2014.01.003] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
253 Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics. 2009;29:1725-1748. [PMID: 19959518 DOI: 10.1148/rg.296095515] [Cited by in Crossref: 273] [Cited by in F6Publishing: 234] [Article Influence: 22.8] [Reference Citation Analysis]
254 Fu G, Du Y, Zee C, Yang H, Li Y, Duan R, Zeng N, Xiao D. Gadobenate Dimeglumine–Enhanced Liver Magnetic Resonance Imaging: Value of Hepatobiliary Phase for the Detection of Focal Liver Lesions. Journal of Computer Assisted Tomography 2012;36:14-9. [DOI: 10.1097/rct.0b013e31823dc139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
255 Ringe KI, Husarik DB, Gupta RT, Boll DT, Merkle EM. Hepatobiliary transit times of gadoxetate disodium (Primovist®) for protocol optimization of comprehensive MR imaging of the biliary system--what is normal? Eur J Radiol. 2011;79:201-205. [PMID: 20347540 DOI: 10.1016/j.ejrad.2010.03.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
256 Frydrychowicz A, Lubner MG, Brown JJ, Merkle EM, Nagle SK, Rofsky NM, Reeder SB. Hepatobiliary MR imaging with gadolinium-based contrast agents. J Magn Reson Imaging. 2012;35:492-511. [PMID: 22334493 DOI: 10.1002/jmri.22833] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 9.8] [Reference Citation Analysis]
257 Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M, Schima W. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol. 2013;23:2187-2196. [PMID: 23519439 DOI: 10.1007/s00330-013-2824-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
258 Kühn JP, Hegenscheid K, Siegmund W, Froehlich CP, Hosten N, Puls R. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol. AJR Am J Roentgenol. 2009;193:1318-1323. [PMID: 19843748 DOI: 10.2214/ajr.09.2412] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
259 Steffen IG, Weissmann T, Rothe JH, Geisel D, Chopra SS, Kahn J, Hamm B, Denecke T. Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI? J Clin Med 2020;10:E98. [PMID: 33396634 DOI: 10.3390/jcm10010098] [Reference Citation Analysis]
260 Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. Radiology. 2010;256:806-816. [PMID: 20720069 DOI: 10.1148/radiol.10091334] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 14.8] [Reference Citation Analysis]
261 Noda Y, Goshima S, Takai Y, Kawai N, Kawada H, Tanahashi Y, Matsuo M. Detection of pancreatic ductal adenocarcinoma and liver metastases: comparison of Gd-EOB-DTPA-enhanced MR imaging vs. extracellular contrast materials. Abdom Radiol (NY) 2020;45:2459-68. [PMID: 32248260 DOI: 10.1007/s00261-020-02511-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
262 Kwon HJ, Byun JH, Kim JY, Hong GS, Won HJ, Shin YM, Kim PN. Differentiation of small (≤2 cm) hepatocellular carcinomas from small benign nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images. Abdom Imaging. 2015;40:64-75. [PMID: 24997560 DOI: 10.1007/s00261-014-0188-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
263 Jeong HT, Kim MJ, Park MS, Choi JY, Choi JS, Kim KS, Choi GH, Shin SJ. Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging. J Magn Reson Imaging. 2012;35:635-643. [PMID: 22095933 DOI: 10.1002/jmri.22880] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
264 Hwang J, Kim SH, Lee MW, Lee JY. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol 2012;85:e314-22. [PMID: 22167508 DOI: 10.1259/bjr/27727228] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
265 Higaki A, Ito K, Tamada T, Teruki S, Yamamoto A, Higashi H, Kanki A, Sato T, Noda Y. High-risk nodules detected in the hepatobiliary phase of Gd-EOB-DTPA-enhanced mr imaging in cirrhosis or chronic hepatitis: Incidence and predictive factors for hypervascular transformation, preliminary results. J Magn Reson Imaging 2013;37:1377-83. [DOI: 10.1002/jmri.23933] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
266 Motosugi U, Ichikawa T, Sano K, Sou H, Onohara K, Muhi A, Amemiya F, Enomoto N, Matsuda M, Fujii H. Outcome of hypovascular hepatic nodules revealing no gadoxetic acid uptake in patients with chronic liver disease. J Magn Reson Imaging. 2011;34:88-94. [PMID: 21608068 DOI: 10.1002/jmri.22630] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
267 Lee NK, Kim S, Kim GH, Heo J, Seo HI, Kim TU, Kang DH. Significance of the "delayed hyperintense portal vein sign" in the hepatobiliary phase MRI obtained with Gd-EOB-DTPA. J Magn Reson Imaging. 2012;36:678-685. [PMID: 22649000 DOI: 10.1002/jmri.23700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
268 Moche M, Heinig S, Garnov N, Fuchs J, Petersen TO, Seider D, Brandmaier P, Kahn T, Busse H. Navigated MRI-guided liver biopsies in a closed-bore scanner: experience in 52 patients. Eur Radiol 2016;26:2462-70. [PMID: 26563349 DOI: 10.1007/s00330-015-4097-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
269 Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. J Magn Reson Imaging. 2013;37:903-908. [PMID: 23065959 DOI: 10.1002/jmri.23874] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
270 Hwang J, Kim SH, Kim Y, Lee MW, Woo JY, Lee WJ, Lim HK. Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy. J Magn Reson Imaging 2010;32:629-38. [DOI: 10.1002/jmri.22287] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
271 Shaw CM, Eisenbrey JR, Lyshchik A, O'kane PL, Merton DA, Machado P, Pino L, Brown DB, Forsberg F. Contrast-Enhanced Ultrasound Evaluation of Residual Blood Flow to Hepatocellular Carcinoma After Treatment With Transarterial Chemoembolization Using Drug-Eluting Beads: A Prospective Study. Journal of Ultrasound in Medicine 2015;34:859-67. [DOI: 10.7863/ultra.34.5.859] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
272 Caraiani CN, Marian D, Militaru C, Calin A, Badea R. The role of the diffusion sequence in magnetic resonance imaging for the differential diagnosis between hepatocellular carcinoma and benign liver lesions. Clujul Med. 2016;89:241-249. [PMID: 27152076 DOI: 10.15386/cjmed-567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
273 Chiorean L, Cantisani V, Jenssen C, Sidhu P, Baum U, Dietrich C. Focal masses in a non-cirrhotic liver: The additional benefit of CEUS over baseline imaging. European Journal of Radiology 2015;84:1636-43. [DOI: 10.1016/j.ejrad.2015.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
274 Geller J, Kasahara M, Martinez M, Soresina A, Kashanian F, Endrikat J. Safety and Efficacy of Gadoxetate Disodium-Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years-Results of a Retrospective, Multicenter Study. Magn Reson Insights 2016;9:21-8. [PMID: 27478381 DOI: 10.4137/MRI.S39091] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
275 Ivashchenko OV, Rijkhorst EJ, Ter Beek LC, Hoetjes NJ, Pouw B, Nijkamp J, Kuhlmann KFD, Ruers TJM. A workflow for automated segmentation of the liver surface, hepatic vasculature and biliary tree anatomy from multiphase MR images. Magn Reson Imaging 2020;68:53-65. [PMID: 31935445 DOI: 10.1016/j.mri.2019.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
276 Courtier JL, Perito ER, Rhee S, Tsai P, Heyman MB, MacKenzie JD. Targeted MRI contrast agents for pediatric hepatobiliary disease. J Pediatr Gastroenterol Nutr. 2012;54:454-462. [PMID: 22193178 DOI: 10.1097/mpg.0b013e3182467a4b] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
277 Albrecht MH, Bodelle B, Varga-Szemes A, Dewes P, Bucher AM, Ball BD, De Cecco CN, Schoepf UJ, Zhu X, Zangos S, Gruber-Rouh T, Wichmann JL, Lehnert T, Vogl TJ. Intra-individual comparison of CAIPIRINHA VIBE technique with conventional VIBE sequences in contrast-enhanced MRI of focal liver lesions. Eur J Radiol 2017;86:20-5. [PMID: 28027748 DOI: 10.1016/j.ejrad.2016.10.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
278 Kim SM, Heo SH, Kim JW, Lim HS, Shin SS, Jeong YY, Kang HK. Hepatic arterial phase on gadoxetic acid-enhanced liver MR imaging: a randomized comparison of 0.5 mL/s and 1 mL/s injection rates. Korean J Radiol 2014;15:605-12. [PMID: 25246821 DOI: 10.3348/kjr.2014.15.5.605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
279 Schwope RB, May LA, Reiter MJ, Lisanti CJ, Margolis DJ. Gadoxetic acid: pearls and pitfalls. Abdom Imaging. 2015;40:2012-2029. [PMID: 25613332 DOI: 10.1007/s00261-015-0354-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
280 Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN; Americas Hepato-Pancreato-Biliary Association; Society of Surgical Oncology; Society for Surgery of the Alimentary Tract. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91-103. [PMID: 23297719 DOI: 10.1111/j.1477-2574.2012.00557.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 155] [Article Influence: 20.0] [Reference Citation Analysis]
281 Haas Y, Dosch MP, Vogl TJ. Response comparison of PLC and SLC with magnetic resonance elastography after TACE. Sci Rep 2022;12:8317. [PMID: 35585124 DOI: 10.1038/s41598-022-12478-w] [Reference Citation Analysis]
282 Muellner A, Glazer GM, Reiser MF, Bradley WG Jr, Krestin GP, Hricak H, Thrall JH. Advancing radiology through informed leadership: summary of the proceedings of the Seventh Biannual Symposium of the International Society for Strategic Studies in Radiology (IS(3)R), 23-25 August 2007. Eur Radiol 2009;19:1827-36. [PMID: 19277668 DOI: 10.1007/s00330-009-1370-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
283 Fowler KJ, Mcconathy J, Narra VR. Whole-body simultaneous positron emission tomography (PET)-MR: Optimization and adaptation of MRI sequences: MR Optimization and Adaptation in PET/MR. J Magn Reson Imaging 2014;39:259-68. [DOI: 10.1002/jmri.24308] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
284 Kim YK, Kim CS, Han YM, Yu HC, Choi D. Detection of small hepatocellular carcinoma: intraindividual comparison of gadoxetic acid-enhanced MRI at 3.0 and 1.5 T. Invest Radiol. 2011;46:383-389. [PMID: 21467946 DOI: 10.1097/rli.0b013e318217b8fb] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
285 Zhang W, Wang X, Miao Y, Hu C, Zhao W. Liver function correlates with liver-to-portal vein contrast ratio during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MR at 3 Tesla. Abdom Radiol (NY) 2018;43:2262-9. [PMID: 29476347 DOI: 10.1007/s00261-018-1462-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
286 Gao W, Jiang B, Kacher DF, Fetics B, Nevo E, Lee TC, Jayender J. Real-time probe tracking using EM-optical sensor for MRI-guided cryoablation. Int J Med Robot 2018;14. [PMID: 29193606 DOI: 10.1002/rcs.1871] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
287 Lee D, Cho ES, Kim DJ, Kim JH, Yu JS, Chung JJ. Validation of 10-Minute Delayed Hepatocyte Phase Imaging with 30° Flip Angle in Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastasis. PLoS One 2015;10:e0139863. [PMID: 26444677 DOI: 10.1371/journal.pone.0139863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
288 Zech CJ, Grazioli L, Jonas E, Ekman M, Niebecker R, Gschwend S, Breuer J, Jönsson L, Kienbaum S. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden. Eur Radiol. 2009;19 Suppl 3:S753-S763. [PMID: 19484243 DOI: 10.1007/s00330-009-1432-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]